| The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group New England Journal of Medicine 330 (15), 1029-1035, 1994 | 2140 | 1994 |
| α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study … D Albanes, OP Heinonen, PR Taylor, J Virtamo, BK Edwards, ... JNCI: Journal of the National Cancer Institute 88 (21), 1560-1570, 1996 | 1182 | 1996 |
| A mutation in the surfactant protein C gene associated with familial interstitial lung disease LM Nogee, AE Dunbar, SE Wert, F Askin, A Hamvas, JA Whitsett New England Journal of Medicine 344 (8), 573-579, 2001 | 1087 | 2001 |
| Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis G Zhen, C Wen, X Jia, Y Li, JL Crane, SC Mears, FB Askin, FJ Frassica, ... Nature medicine 19 (6), 704-712, 2013 | 944 | 2013 |
| Malignant small cell tumor of the thoracopulmonary region in childhood. A distinctive clinicopathologic entity of uncertain histogenesis FB Askin, J Rosai, RK Sibley, LP Dehner, WH McAlister Cancer 43 (6), 2438-2451, 1979 | 857 | 1979 |
| Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to … L Osmani, F Askin, E Gabrielson, QK Li Seminars in cancer biology 52, 103-109, 2018 | 749 | 2018 |
| Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. ME Nesbit Jr, EA Gehan, EO Burgert Jr, TJ Vietti, A Cangir, M Tefft, ... Journal of Clinical Oncology 8 (10), 1664-1674, 1990 | 676 | 1990 |
| Microsatellite alterations as clonal markers for the detection of human cancer. L Mao, DJ Lee, MS Tockman, YS Erozan, F Askin, D Sidransky Proceedings of the National Academy of Sciences 91 (21), 9871-9875, 1994 | 592 | 1994 |
| Diffuse lung disease in young children: application of a novel classification scheme GH Deutsch, LR Young, RR Deterding, LL Fan, SD Dell, JA Bean, ... American journal of respiratory and critical care medicine 176 (11), 1120-1128, 2007 | 591 | 2007 |
| Katzenstein and Askin's surgical pathology of non-neoplastic lung disease ALA Katzenstein Saunders, 2006 | 577* | 2006 |
| Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: a Gynecologic Oncology Group pathologic study of 203 cases SG Silverberg, FJ Major, JA Blessing, B Fetter, FB Askin, SY Liao, A Miller International journal of gynecological pathology 9 (1), 1-19, 1990 | 494 | 1990 |
| Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC) TR Cottrell, ED Thompson, PM Forde, JE Stein, AS Duffield, ... Annals of Oncology 29 (8), 1853-1860, 2018 | 436 | 2018 |
| Mycobacterial catalase–peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis Z Song, L Marzilli, BM Greenlee, ES Chen, RF Silver, FB Askin, ... The Journal of experimental medicine 201 (5), 755-767, 2005 | 416 | 2005 |
| SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801 A Wahl, LE Gralinski, CE Johnson, W Yao, M Kovarova, KH Dinnon III, ... Nature 591 (7850), 451-457, 2021 | 411 | 2021 |
| The cellular origin of pulmonary surfactant. FB Askin, C Kuhn | 375 | 1971 |
| K-ras Oncogene Activation in Atypical Alveolar Hyperplasias of the Human Lung WH Westra, IO Baas, RH Hruban, FB Askin, K Wilson, GJA Offerhaus, ... Cancer research 56 (9), 2224-2228, 1996 | 302 | 1996 |
| Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. CK Conrad, SS Allen, SA Afione, TC Reynolds, SE Beck, M Fee-Maki, ... Gene Therapy 3 (8), 658-668, 1996 | 285 | 1996 |
| Neuroblastoma and the differential diagnosis of small-, round-, blue-cell tumors MJ Finegold, TJ Triche, FB Askin Human pathology 14 (7), 569-595, 1983 | 282 | 1983 |
| K‐ras oncogene activation in lung adenocarcinomas from former smokers evidence that K‐ras mutations are an early and irreversible event in the development of adenocarcinoma of … WH Westra, RJC Slebos, GJA Offerhaus, SN Goodman, SG Evers, ... Cancer 72 (2), 432-438, 1993 | 269 | 1993 |
| Clinical and pathologic predictors of survival in patients with thymoma KB Wilkins, E Sheikh, R Green, M Patel, S George, M Takano, ... Annals of surgery 230 (4), 562, 1999 | 254 | 1999 |
